U.S. drugmaker stocks fall ahead of Trump’s pricing executive orders
Shares of U.S. drugmakers fell on Friday, ahead of executive orders by U.S. President Donald Trump aimed at lowering drug prices.
With a re-election race underway and the coronavirus pandemic raging in the country, the White House is looking to bring down drug prices by reportedly considering tying them to what consumers outside the United States pay.
The SandP 500 was down 1.3 per cent, with drugmakers such as Regeneron Pharmaceuticals Inc and Pfizer inc weighing on the index. The declines were in line with a fall in broader markets.
Source: Jordan News Agency